CU20110041A7 - DIOXA-BICYCLE DERIVATIVES (3.2.1) OCTANO-2,3,4-TRIOL - Google Patents
DIOXA-BICYCLE DERIVATIVES (3.2.1) OCTANO-2,3,4-TRIOLInfo
- Publication number
- CU20110041A7 CU20110041A7 CU20110041A CU20110041A CU20110041A7 CU 20110041 A7 CU20110041 A7 CU 20110041A7 CU 20110041 A CU20110041 A CU 20110041A CU 20110041 A CU20110041 A CU 20110041A CU 20110041 A7 CU20110041 A7 CU 20110041A7
- Authority
- CU
- Cuba
- Prior art keywords
- octano
- dioxa
- triol
- bicycle derivatives
- bicycle
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 abstract 1
- 108091052347 Glucose transporter family Proteins 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En el presente documento se describen compuestos de fórmula (I) y usos de los mismos para el tratamiento de enfermedades, afecciones y/o trastornos mediados por inhibidores del transportador de glucosa dependiente de sodio (en particular, inhibidores de SGLT2). ESPACIO PARA LA FÓRMULACompounds of formula (I) and uses thereof for the treatment of diseases, conditions and / or disorders mediated by sodium-dependent glucose transporter inhibitors (in particular, SGLT2 inhibitors) are described herein. FORMULA SPACE
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22721209P | 2009-07-21 | 2009-07-21 | |
| PCT/IB2009/053626 WO2010023594A1 (en) | 2008-08-28 | 2009-08-17 | Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20110041A7 true CU20110041A7 (en) | 2011-12-28 |
| CU24003B1 CU24003B1 (en) | 2014-06-27 |
Family
ID=45508744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2011000041A CU24003B1 (en) | 2009-07-21 | 2011-02-25 | DIOXA-BICYCLE DERIVATIVES (3.2.1) OCTANO-2,3,4-TRIOL |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU24003B1 (en) |
-
2011
- 2011-02-25 CU CU2011000041A patent/CU24003B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CU24003B1 (en) | 2014-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP11010854A (en) | DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL | |
| CR20120289A (en) | DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL | |
| CY1120690T1 (en) | CRYSTAL FORM OF BENZYLOVENZOLE SUBSTANCE OF SGLT2 | |
| CY1119810T1 (en) | DERIVATIVE (2S, 3R, 4R, 5S, 6R) -2- (4-CHLORO-3-BENZYLFINYL) -6- (HYDROXYMETHYL) tetrahydro-2H-PYRAN-3,4,5-TRIOLIS FOR USE | |
| CL2008003473A1 (en) | Heterocycle substituted phenylpiperidine derivative compounds; preparation procedure; pharmaceutical composition comprising it; and use in the treatment of cardiovascular, thromboembolic and tumor disorders; in vitro uses. | |
| DOP2013000267A (en) | HYDROXIMETHYL PIRROLIDINS AS AGONISTS OF THE BETA 3 ADRENERAL RECEIVER | |
| DOP2011000279A (en) | BENZOFURANILO DERIVATIVES USED AS GLUCOQUINASE INHIBITORS | |
| UY32882A (en) | (HETEROARILMETIL) SUBSTITUTED THIOHIDANTOINS | |
| UY30835A1 (en) | 8-ALQUINILXANTINAS AND DERIVATIVES | |
| CL2008002793A1 (en) | Compounds derived from substituted amides, inhibitors of btk activity; pharmaceutical composition comprising them; Useful in the treatment of cancer, bone disorders, autoimmune diseases, among others | |
| UY32848A (en) | OXIMA HETEROCYCLIC COMPOUNDS | |
| CU20130063A7 (en) | PRODUCTION PROCESS OF CYCLIC DEPSIPEPTIDES | |
| NZ707859A (en) | Inhibitors of sodium glucose cotransporter 1 | |
| UY30220A1 (en) | TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE | |
| UY32315A (en) | PIPERIDINE COMPOUNDS AND USES OF THE SAME-596 | |
| CO6341625A2 (en) | DERIVATIVES OF INDOL AS ANTI-CANCER AGENTS | |
| CL2011001829A1 (en) | 3'-n-desmethyl-4 '' - o- (2-diethylaminoetanoyl) -6-o-methyl-9a-aza-9a-homoerythromycin a, its salts and crystalline forms 1, 2 and 3; Preparation process; use to treat inflammatory diseases; pharmaceutical composition; and composition which also comprises another active compound. | |
| AR071762A1 (en) | 5-HYDROXIMETHYL-OXAZOLIDIN-2-ONA DERIVATIVES FOR THE TREATMENT OF BACTERIAL INTESTINAL DISEASES | |
| CO6460762A2 (en) | 5-ALQUINIL-PIRIDINAS | |
| AR076520A1 (en) | BLOOD PARASITICIDES. COMPOSITION | |
| CU20110041A7 (en) | DIOXA-BICYCLE DERIVATIVES (3.2.1) OCTANO-2,3,4-TRIOL | |
| AR081882A1 (en) | CRYSTALLINE FORM OF INHIBITING BENCILBENCENO OF SGLT2 | |
| UY31425A1 (en) | PHENYLPIRROLIDINE COMPOUNDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent |